trending Market Intelligence /marketintelligence/en/news-insights/trending/obq2okaq-v-ylm1qlpueda2 content esgSubNav
In This List

Webster Capital acquires JBR Clinical Research

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Webster Capital acquires JBR Clinical Research

Webster Capital said it acquired JBR Clinical Research, a Salt Lake City-based clinical research site manager that conducts studies on behalf of pharmaceutical companies.

The Waltham, Mass.-based private equity firm did not disclose financial details of the transaction.

"JBR helps reduce both the cost and time to bring a drug to market, creating value for sponsors and patients across the world," Mehran Ahmed, principal at Webster Capital, said in a news release.